Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

352
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
352
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

647
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
647

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overexpression of a GIPC glycosyltransferase gene, OsGMT1, suppresses plant immunity and delays heading time in rice.

Plant science : an international journal of experimental plant biology·2023
Same author

Hydrocarbons in the Meniscus: Effects on Conductive Atomic Force Microscopy.

Langmuir : the ACS journal of surfaces and colloids·2023
Same author

Unexplained Female Infertility Associated with Genetic Disease Variants.

The New England journal of medicine·2023
Same author

A bibliometric analysis of sleep in older adults.

Frontiers in public health·2023
Same author

Preparation, characterisation, and in vitro cancer-suppression function of RNA nanoparticles carrying miR-301b-3p Inhibitor.

IET nanobiotechnology·2023
Same author

Localization of senescent cells under cavity preparations in rats and restoration of reparative dentin formation by senolytics.

Dental materials journal·2023

Related Experiment Video

Updated: Jun 22, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K

DKPE-GraphSYN: a drug synergy prediction model based on joint dual kernel density estimation and positional encoding

Yunyun Dong1, Yujie Bai1, Haitao Liu1

  • 1School of Software, Taiyuan University of Technology, Taiyuan, Shanxi, China.

Frontiers in Genetics
|July 1, 2024
PubMed
Summary

This study introduces DKPEGraphSYN, a novel deep learning model for predicting cancer drug synergy. The model accurately forecasts drug combinations, improving therapeutic strategies and patient outcomes in cancer treatment.

Keywords:
cancer treatmentdeep learningdrug combinationdrug-drug interaction predictiongraph attention networksynergistic effect

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Related Experiment Videos

Last Updated: Jun 22, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K

Area of Science:

  • Computational Biology
  • Pharmacology
  • Artificial Intelligence in Medicine

Background:

  • Synergistic medication is vital for cancer treatment, enhancing efficacy and reducing side effects.
  • Current deep learning models for drug synergy prediction overlook complex data relationships and drug structural information.

Purpose of the Study:

  • To develop an advanced end-to-end learning model for predicting cancer drug combination synergy.
  • To address limitations in existing models by incorporating gene expression distribution and drug molecule interactions.

Main Methods:

  • Introduced Dual Kernel Density and Positional Encoding for Graph Synergy Representation Network (DKPEGraphSYN).
  • Utilized Dual Kernel Density Estimation and Positional Encoding to capture gene expression data characteristics.
  • Employed graph neural networks to explore interactions between cancer drug molecules.

Main Results:

  • DKPEGraphSYN achieved significant performance enhancements in predicting drug synergy effects.
  • The model obtained an Area Under the Precision-Recall Curve (AUPR) of 0.969 and an Area Under the Curve (AUC) of 0.976.
  • Demonstrated superior accuracy on a comprehensive cancer drug and cell line synergy dataset.

Conclusions:

  • DKPEGraphSYN accurately predicts cancer drug combinations, offering a valuable tool for clinical decision-making.
  • The model's ability to capture complex data relationships enhances therapeutic strategy development in oncology.